Cannabis
AgriCann Solutions Appoints CFO & Director
Vancouver, British Columbia–(Newsfile Corp. – August 6, 2021) – AgriCann Solutions Corp. (the “Company” or “AgriCann“), a licensed full-service cannabis nursery operator, is pleased to announce appointment of Mr. Dome Duong, CPA, CA as AgriCann’s Chief Financial Officer, and as a director of the Company.
Mr.Duong is a highly experienced financial professional and leader. Prior to joining AgriCann, he led the cannabis practice at PDC Business & Taxes as CFO and has advised private and public clients on corporate finance, capital raises, M&A, tax, financial reporting and cost accounting. In addition, he has held roles as fractional CFO to his cannabis clients. Prior tenures include Ernst & Young, MNP and BDO. Mr. Duong obtained a Chartered Accountant and Chartered Professional Accountant (Canada) designation, holds a B.A. Degree from the University of Alberta, and is an Executive MBA candidate at Queen’s University.
About AgriCann Solutions Corp.
AgriCann Solutions Corp. is a “Reporting Issuer” created as result of a statutory plan of arrangement completed by The Valens Company in 2015. AgriCann operates wholly owned subsidiary Craft Nurseries Canada Inc. (“CNC”), licensed under the Cannabis Act and Cannabis Regulations on May 21, 2021 to produce and sell unique premium cannabis and hemp genetics, including clones, pre-veg and veg plants, to licensed producers and cannabis retail stores. AgriCann is currently executing an aggressive buy-and-build roll-up strategy with four highly accretive acquisitions pending completion (see June 25, 2021 news release).
AgriCann currently has 13,480,758 Common Shares outstanding. Upon completion of all the transactions and funding contemplated herein without further adjustments, it is expected to have 49,680,758 shares outstanding.
ON BEHALF OF AGRICANN SOLUTIONS CORP.
(signed) “Rob van Santen”
CEO & Director
For further information, please contact:
Robert van Santen, CA, CPA, CMT
Telephone: +1.604.608.1999
Some of the statements contained in this press release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “expects”, “intends”, “is expected”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company’s control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law. The Company will provide further updates respecting these initiatives as developments occur. There can be no assurance that interests in any or all of these or additional projects being pursued will be acquired, funded and/or commercialized.
AgriCann Solutions Corp.
400-1771 Robson Street, Vancouver, BC, Canada V6G 1C9
Tel. +1.604.608.1999 ~ Fax. +1.778.379.9990
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92380
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace